Bunka Christopher's Form 4/A amendment
AmendedLexaria Bioscience Corp. (LEXX) · filed Oct 18, 2022
- Accession no.
- 0001855763-22-000019
- Filed
- Oct 18, 2022
- Trade date
- Oct 12-13, 2022
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Oct 13, 2022
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $78.4K. It was filed 6 days after the trade.
This amendment replaces 0001855763-22-000014 (filed Oct 13, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bunka ChristopherCIK 0001103780 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2022 | common shares | PPurchaseAcquired | +21,900 | $1.99 | +$43,581 | 237,812 | Indirect | |
| Oct 13, 2022 | common shares | PPurchaseAcquired | +16,600 | $2.10 | +$34,860 | 254,412 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.